Feeding the Pipeline: Novel Targets for Alzheimer’s Drug Discovery - Nov 3, 2010
A one-day meeting focusing on European biotechnology companies conducting early-stage high risk research for Alzheimer’s disease that complement approaches in advanced clinical trials. This is a satellite meeting to be held in conjunction with the 3rd Clinical Trials on Alzheimer’s Disease conference.